Introduction
High Altitude Cerebral Edema (HACE) has an incidence rate of only 0.5–1%, yet it is one of the most fatal complications of high-altitude activities. It almost always evolves from AMS and deteriorates extremely rapidly—the literature documents multiple cases of climbers progressing from “just a headache” to coma in only 12 hours. Although Taiwan’s elevations do not match the Himalayas, Yushan Main Peak at 3,952 m and Xue Mountain at 3,886 m already fall within the HACE risk range. This article is based on the Wilderness Medical Society 2024 consensus to help climbers and guides with early recognition.
The Pathology of HACE: Loss of Cerebral Pressure Control
HACE is a cerebral edema combining both vasogenic and cytotoxic components. Hypoxia increases blood-brain barrier permeability, allowing fluid to leak into brain tissue; combined with failed cerebral autoregulation, intracranial pressure rises and compresses the cerebellum and brainstem. MRI imaging studies (Hackett et al.) show typical T2 hyperintensity in the splenium of the corpus callosum in HACE patients.
Key Warning Signs: Ataxia and Altered Consciousness
WMS diagnostic criteria: in the presence of AMS or HAPE, any of the following newly appearing signs constitutes HACE:
| Warning Sign | Bedside Test | Severity |
|---|---|---|
| Ataxia | Tandem gait—walk 4 meters in a straight line | Most sensitive in early stage |
| Altered consciousness | Disoriented to person, place, or time | Moderate |
| Severe lethargy | Difficult to arouse | Moderate |
| Behavioral changes | Irritability, hallucinations | Moderate |
| Coma | GCS <13 | End stage |
Tandem gait test method: Draw a straight line on the ground and have the patient walk 4 meters heel-to-toe. AMS patients can usually manage with effort, while HACE patients will visibly sway side to side or miss the line. This is a 30-second screening test that every Taiwanese guide must know.
Three Treatment Principles
- Immediate descent: Descending 500–1,000 m is the most effective treatment; every minute counts.
- Dexamethasone: 8 mg immediately by mouth or intramuscular injection, followed by 4 mg every 6 hours.
- Oxygen or hyperbaric bag (Gamow bag): Oxygen at 2–4 L/min to maintain SpO₂ >90%; pressurizing the hyperbaric bag to 2 psi is roughly equivalent to descending 1,500 m.
Practical Recommendations
- Guides must memorize the tandem gait test: At Paiyun Lodge on Yushan or 369 Lodge on Xue Mountain, if a team member complains of a headache at night, perform the test immediately.
- Buddy system: HACE patients often feel they are “fine” (because their judgment is already impaired), so observation by a companion is essential.
- Weather and time window: Descent from Yushan to the Tataka trailhead takes approximately 5–7 hours. If it is already dark or weather is deteriorating, stabilize the patient with dexamethasone and oxygen first, then depart at first light.
- Prevention is treatment: Anyone who has previously experienced HACE should take prophylactic acetazolamide 125 mg bid starting 24 hours before ascending above 3,000 m again.
Conclusion
HACE is not a curse of the mountains, but the price of delayed recognition. Learn the tandem gait test, carry dexamethasone (a prescription drug for team leaders), and remember the iron rule “ataxia equals descent”—this adds a life-saving layer of protection to high-mountain travel in Taiwan.